Patents by Inventor Ieva Jaunzeme

Ieva Jaunzeme has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
    Patent number: 7598384
    Abstract: The invention relates to tetrahydroquinolinone derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are group I mGluR antagonists and are therefore useful for the control and prevention of acute and/or chronic neurological disorders.
    Type: Grant
    Filed: February 25, 2005
    Date of Patent: October 6, 2009
    Assignee: Merz Pharma GmbH & Co. KGAA
    Inventors: Aigars Jirgensons, Christopher Graham Raphael Parsons, Ieva Jaunzeme, Ivars Kalvinsh, Markus Henrich, Maksims Vanejevs, Tanja Weil, Valerjans Kauss, Wojciech Danysz
  • Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
    Publication number: 20090227582
    Abstract: The invention relates to ethynyl-substituted tetrahydroquinolinone derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are group I mGluR modulators and are therefore useful for the control and prevention of acute and/or chronic neurological disorders.
    Type: Application
    Filed: May 8, 2009
    Publication date: September 10, 2009
    Applicant: MERZ PHARMA GMBH & CO. KGAA
    Inventors: Valerjans Kauss, Ieva Jaunzeme, Aigars Jirgensons, Ivars Kalvinsh, Maksims Vanejevs, Markus Henrich, Wojciech Danysz, Claudia Jatzke, Christopher G.R. Parsons, Tanja Weil
  • Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
    Patent number: 7550482
    Abstract: The invention relates to ethynyl-substituted tetrahydroquinolinone derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are group I mGluR modulators and are therefore useful for the control and prevention of acute and/or chronic neurological disorders.
    Type: Grant
    Filed: August 24, 2005
    Date of Patent: June 23, 2009
    Assignee: Merz Pharma GmbH & Co. KGAA
    Inventors: Valerjans Kauss, Ieva Jaunzeme, Aigars Jirgensons, Ivars Kalvinsh, Maksims Vanejevs, Markus Henrich, Wojciech Danysz, Claudia Jatzke, Christopher Graham Raphael Parsons, Tanja Weil
  • Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
    Publication number: 20060004001
    Abstract: The invention relates to tetrahydroquinolinone derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are group I mGluR modulators and are therefore useful for the control and prevention of acute and/or chronic neurological disorders.
    Type: Application
    Filed: August 25, 2005
    Publication date: January 5, 2006
    Applicant: MERZ PHARMA GMBH & CO., KGAA
    Inventors: Aigars Jirgensons, Christopher Parsons, Ieva Jaunzeme, Ivars Kalvinsh, Markus Henrich, Maksims Vanejevs, Tanja Weil, Valerjans Kauss, Wojciech Danysz
  • Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
    Publication number: 20050288284
    Abstract: The invention relates to ethynyl-substituted tetrahydroquinolinone derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are group I mGluR modulators and are therefore useful for the control and prevention of acute and/or chronic neurological disorders.
    Type: Application
    Filed: August 24, 2005
    Publication date: December 29, 2005
    Applicant: MERZ PHARMA GMBH & CO. KGAA
    Inventors: Aigars Jirgensons, Christopher Parsons, Ieva Jaunzeme, Ivars Kalvinsh, Markus Henrich, Maksims Vanejevs, Tanja Weil, Valerjans Kauss, Wojciech Danysz
  • Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
    Publication number: 20050197361
    Abstract: The invention relates to tetrahydroquinolinone derivatives as well as their pharmaceutially acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are group I mGluR antagonists and are therefore useful for the control and prevention of acute and/or chronic neurological disorders.
    Type: Application
    Filed: February 25, 2005
    Publication date: September 8, 2005
    Applicant: MERZ PHARMA GMBH & CO. KGAA
    Inventors: Aigars Jirgensons, Christopher Parsons, Ieva Jaunzeme, Ivars Kalvinsh, Markus Henrich, Maksims Vanejevs, Tanja Weil, Valerjans Kauss, Wojciech Danysz